Which of the following variables must be considered when the decision to start antihypertensive drug therapy is being initiated? Select all that apply
a. Stage and degree of blood pressure elevation
b. Adherence to therapy with once-daily dosing
c. Presence of clinical cardiovascular or other risk factors
d. Presence of end-organ damage
e. Safety profile of the specific drug or drugs
f. Reduced risk of sudden death, heart attack, and stroke caused by abrupt increases in blood pressure after arising
ANS: A, C, D, E
The decision to start antihypertensive drug therapy requires careful consideration of several fac-tors including the following:
? Stage and degree of blood pressure elevation
? Presence of clinical cardiovascular or other risk factors
? Presence of end-organ damage
? Safety profile of the specific drug or drugs
? Efficacy and convenience of specific drug or drugs
? Potential for drug interactions
?????Treatment costs, including laboratory testing, and follow-up visits to health care provider.
You might also like to view...
A patient with Parkinson's disease is taking levodopa/carbidopa [Sinemet] along with amanta-dine [Symmetrel] 400 mg/day to treat dyskinesias. The patient reports having increased dyskine-sias several months after beginning the amantadine
The nurse will contact the provider to discuss which action? a. Increasing the dose of amantadine [Sym-metrel] b. Interrupting treatment with amantadine for several weeks c. Ordering renal function tests d. Ordering another anticholinergic medica-tion
The nurse is preparing to provide education to a client with a diagnosis of a malignant neoplasm. What is the nurse's understanding of the client's condition?
A) This condition is life-threatening. B) In this condition, cells typically grow slowly. C) Malignant cells have minimal nuclear variation in size and shape. D) Malignant cells represent a range of ploidy statuses.
The nurse is caring for a client who is receiving sodium hyaluronate (Hyalgan) injections. What should the nurse include in the medication teaching?
1. Continue with all activities following injection, so as not to cause stiffness. 2. Increase ROM to joint for better dispersal of the medication. 3. No weight bearing on the joint following injection. 4. Avoid strenuous exercise for 48 hours after injection.
The nurse is administering iron-dextran (Imferon) to a child diagnosed with iron-deficiency anemia. How should the nurse give this medication?
A) Intravenous B) Rectal C) Intramuscular D) Subcutaneous